New AI test identifies prostate cancer patients who benefit from abiraterone
Using the new AI test, they found that abiraterone given alongside standard hormone therapy almost halves the risk of death for approximately 25% of ...
Read the original at News-Medical.Net ↗
- Topics
- Healthcare
- Tracked via
- “AI Risks”